-
1
-
-
32044454664
-
Bayesian methods for evidence synthesis in cost-effectiveness analysis
-
Ades AE, Sculpher M, Sutton A, Abrams K, Cooper N, Welton N, et al.Bayesian methods for evidence synthesis in cost-effectiveness analysis. Pharmacoeconomics 2006;24:1-19.
-
(2006)
Pharmacoeconomics
, vol.24
, pp. 1-19
-
-
Ades, A.E.1
Sculpher, M.2
Sutton, A.3
Abrams, K.4
Cooper, N.5
Welton, N.6
-
2
-
-
77956036473
-
2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
-
Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, 3rd, et al.2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Annals of the Rheumatic Diseases 2010;69:1580-8.
-
(2010)
Annals of the Rheumatic Diseases
, vol.69
, pp. 1580-1588
-
-
Aletaha, D.1
Neogi, T.2
Silman, A.J.3
Funovits, J.4
Felson, D.T.5
Bingham, C.O.6
-
3
-
-
80054724911
-
Expressing findings from meta-analyses of continuous outcomes in terms of risks
-
Anzures-Cabrera J, Sarpatwari A, Higgins JP. Expressing findings from meta-analyses of continuous outcomes in terms of risks. Statistics in Medicine 2011;30:2967-85.
-
(2011)
Statistics in Medicine
, vol.30
, pp. 2967-2985
-
-
Anzures-Cabrera, J.1
Sarpatwari, A.2
Higgins, J.P.3
-
4
-
-
0023945481
-
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
-
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al.The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis & Rheumatism 1988;31:315-24.
-
(1988)
Arthritis & Rheumatism
, vol.31
, pp. 315-324
-
-
Arnett, F.C.1
Edworthy, S.M.2
Bloch, D.A.3
McShane, D.J.4
Fries, J.F.5
Cooper, N.S.6
-
8
-
-
84864570470
-
Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs
-
Bykerk VP, Akhavan P, Hazlewood GS, Schieir O, Dooley A, Haraoui B, et al.Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs. The Journal of Rheumatology 2012;39:1559-82.
-
(2012)
The Journal of Rheumatology
, vol.39
, pp. 1559-1582
-
-
Bykerk, V.P.1
Akhavan, P.2
Hazlewood, G.S.3
Schieir, O.4
Dooley, A.5
Haraoui, B.6
-
10
-
-
0029044362
-
American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis
-
Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al.American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis & Rheumatism 1995;38:727-35.
-
(1995)
Arthritis & Rheumatism
, vol.38
, pp. 727-735
-
-
Felson, D.T.1
Anderson, J.J.2
Boers, M.3
Bombardier, C.4
Furst, D.5
Goldsmith, C.6
-
11
-
-
0038011833
-
Evolving concepts of rheumatoid arthritis
-
Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003;423:356-61.
-
(2003)
Nature
, vol.423
, pp. 356-361
-
-
Firestein, G.S.1
-
12
-
-
0020188574
-
The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales
-
Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. The Journal of Rheumatology 1982;9:789-93.
-
(1982)
The Journal of Rheumatology
, vol.9
, pp. 789-793
-
-
Fries, J.F.1
Spitz, P.W.2
Young, D.Y.3
-
13
-
-
84859495141
-
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011
-
Furst DE, Keystone EC, Braun J, Breedveld FC, Burmester GR, De Benedetti F, et al.Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011. Annals of the Rheumatic Diseases. 2012;71 Suppl 2:i2-45.
-
(2012)
Annals of the Rheumatic Diseases.
, vol.71 SUPPL. 2
, pp. i2-i45
-
-
Furst, D.E.1
Keystone, E.C.2
Braun, J.3
Breedveld, F.C.4
Burmester, G.R.5
De Benedetti, F.6
-
14
-
-
70449732707
-
Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative
-
Gossec L, Dougados M, Rincheval N, Balanescu A, Boumpas DT, Canadelo S, et al.Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative. Annals of the Rheumatic Diseases. 2009;68:1680-5.
-
(2009)
Annals of the Rheumatic Diseases.
, vol.68
, pp. 1680-1685
-
-
Gossec, L.1
Dougados, M.2
Rincheval, N.3
Balanescu, A.4
Boumpas, D.T.5
Canadelo, S.6
-
15
-
-
43049113533
-
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
-
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al.GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-6.
-
(2008)
BMJ
, vol.336
, pp. 924-926
-
-
Guyatt, G.H.1
Oxman, A.D.2
Vist, G.E.3
Kunz, R.4
Falck-Ytter, Y.5
Alonso-Coello, P.6
-
17
-
-
79959960493
-
Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2
-
Hoaglin DC, Hawkins N, Jansen JP, Scott DA, Itzler R, Cappelleri JC, et al.Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2. Value in Health 2011;14:429-37.
-
(2011)
Value in Health
, vol.14
, pp. 429-437
-
-
Hoaglin, D.C.1
Hawkins, N.2
Jansen, J.P.3
Scott, D.A.4
Itzler, R.5
Cappelleri, J.C.6
-
18
-
-
1842425908
-
Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis
-
Hoekstra M, Haagsma C, Neef C, Proost J, Knuif A, van de Laar M. Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis. The Journal of Rheumatology 2004;31:645-8.
-
(2004)
The Journal of Rheumatology
, vol.31
, pp. 645-648
-
-
Hoekstra, M.1
Haagsma, C.2
Neef, C.3
Proost, J.4
Knuif, A.5
van de Laar, M.6
-
19
-
-
52649100566
-
Bayesian meta-analysis of multiple treatment comparisons: an introduction to mixed treatment comparisons
-
Jansen JP, Crawford B, Bergman G, Stam W. Bayesian meta-analysis of multiple treatment comparisons: an introduction to mixed treatment comparisons. Value in Health 2008;11:956-64.
-
(2008)
Value in Health
, vol.11
, pp. 956-964
-
-
Jansen, J.P.1
Crawford, B.2
Bergman, G.3
Stam, W.4
-
20
-
-
79959925787
-
Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1
-
Jansen JP, Fleurence R, Devine B, Itzler R, Barrett A, Hawkins N, et al.Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1. Value in Health 2011;14:417-28.
-
(2011)
Value in Health
, vol.14
, pp. 417-428
-
-
Jansen, J.P.1
Fleurence, R.2
Devine, B.3
Itzler, R.4
Barrett, A.5
Hawkins, N.6
-
21
-
-
77952467678
-
Methotrexate monotherapy versus methotrexate combination therapy with non-biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis
-
Katchamart W, Trudeau J, Phumethum V, Bombardier C. Methotrexate monotherapy versus methotrexate combination therapy with non-biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis. Cochrane Database of Systematic Reviews 2010, Issue 4. [DOI: 10.1002/14651858.CD008495]
-
(2010)
Cochrane Database of Systematic Reviews
, Issue.4
-
-
Katchamart, W.1
Trudeau, J.2
Phumethum, V.3
Bombardier, C.4
-
22
-
-
33750367268
-
Genes, environment and immunity in the development of rheumatoid arthritis
-
Klareskog L, Padyukov L, Rönnelid J, Alfredsson L. Genes, environment and immunity in the development of rheumatoid arthritis. Current Opinion in Immunology 2006;18:650-5.
-
(2006)
Current Opinion in Immunology
, vol.18
, pp. 650-655
-
-
Klareskog, L.1
Padyukov, L.2
Rönnelid, J.3
Alfredsson, L.4
-
23
-
-
77953718691
-
Current evidence for a strategic approach to the management of rheumatoid arthritis with disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis
-
Knevel R, Schoels M, Huizinga TW, Aletaha D, Burmester GR, Combe B, et al.Current evidence for a strategic approach to the management of rheumatoid arthritis with disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis. Annals of the Rheumatic Diseases 2010;69:987-94.
-
(2010)
Annals of the Rheumatic Diseases
, vol.69
, pp. 987-994
-
-
Knevel, R.1
Schoels, M.2
Huizinga, T.W.3
Aletaha, D.4
Burmester, G.R.5
Combe, B.6
-
24
-
-
1442352158
-
Epidemiology and burden of illness of rheumatoid arthritis
-
Kvien TK. Epidemiology and burden of illness of rheumatoid arthritis. Pharmacoeconomics 2004;22:1-12.
-
(2004)
Pharmacoeconomics
, vol.22
, pp. 1-12
-
-
Kvien, T.K.1
-
25
-
-
0017658738
-
Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films
-
Larsen A, Dale K, Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiologica: Diagnosis (Stockh) 1977;18:481-91.
-
(1977)
Acta Radiologica: Diagnosis (Stockh)
, vol.18
, pp. 481-491
-
-
Larsen, A.1
Dale, K.2
Eek, M.3
-
26
-
-
84865655947
-
A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The treatment of early aggressive rheumatoid arthritis trial
-
Moreland LW, O'Dell JR, Paulus HE, Curtis JR, Bathon JM, St Clair EW, et al.A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The treatment of early aggressive rheumatoid arthritis trial. Arthritis & Rheumatism 2012;64:2824-35.
-
(2012)
Arthritis & Rheumatism
, vol.64
, pp. 2824-2835
-
-
Moreland, L.W.1
O'Dell, J.R.2
Paulus, H.E.3
Curtis, J.R.4
Bathon, J.M.5
St Clair, E.W.6
-
27
-
-
77953694972
-
Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA
-
Nam JL, Winthrop KL, van Vollenhoven RF, Pavelka K, Valesini G, Hensor EM, et al.Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA. Annals of the Rheumatic Diseases 2010;69:976-86.
-
(2010)
Annals of the Rheumatic Diseases
, vol.69
, pp. 976-986
-
-
Nam, J.L.1
Winthrop, K.L.2
van Vollenhoven, R.F.3
Pavelka, K.4
Valesini, G.5
Hensor, E.M.6
-
28
-
-
85041961713
-
Rheumatoid Arthritis: The management of rheumatoid arthritis in adults: NICE clinical guidance 79. February 2009
-
National Institute for Clinical Excellence (NICE). Rheumatoid Arthritis: The management of rheumatoid arthritis in adults: NICE clinical guidance 79. February 2009. Available from www.nice.org.uk.
-
-
-
-
30
-
-
0028815803
-
Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis
-
Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis and Rheumatism 1995;38:44-8.
-
(1995)
Arthritis and Rheumatism
, vol.38
, pp. 44-48
-
-
Prevoo, M.L.1
van't Hof, M.A.2
Kuper, H.H.3
van Leeuwen, M.A.4
van de Putte, L.B.5
van Riel, P.L.6
-
31
-
-
85041943842
-
-
R. 2.14.0. The R Foundation for Statistical Computing
-
The R Foundation for Statistical Computing. R. 2.14.0. The R Foundation for Statistical Computing, 2011.
-
(2011)
-
-
-
32
-
-
45349090538
-
American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis
-
Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, et al.American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Care & Research 2008;59:762-84.
-
(2008)
Arthritis Care & Research
, vol.59
, pp. 762-784
-
-
Saag, K.G.1
Teng, G.G.2
Patkar, N.M.3
Anuntiyo, J.4
Finney, C.5
Curtis, J.R.6
-
33
-
-
77951742353
-
Patient perspective of measuring treatment efficacy: the rheumatoid arthritis patient priorities for pharmacologic interventions outcomes
-
Sanderson T, Morris M, Calnan M, Richards P, Hewlett S. Patient perspective of measuring treatment efficacy: the rheumatoid arthritis patient priorities for pharmacologic interventions outcomes. Arthritis Care & Research (Hoboken) 2010;62:647-56.
-
(2010)
Arthritis Care & Research (Hoboken)
, vol.62
, pp. 647-656
-
-
Sanderson, T.1
Morris, M.2
Calnan, M.3
Richards, P.4
Hewlett, S.5
-
34
-
-
0015151774
-
Methods of scoring the progression of radiologic changes in rheumatoid arthritis. Correlation of radiologic, clinical and laboratory abnormalities
-
Sharp JT, Lidsky MD, Collins LC, Moreland J. Methods of scoring the progression of radiologic changes in rheumatoid arthritis. Correlation of radiologic, clinical and laboratory abnormalities. Arthritis and Rheumatism 1971;14:706-20.
-
(1971)
Arthritis and Rheumatism
, vol.14
, pp. 706-720
-
-
Sharp, J.T.1
Lidsky, M.D.2
Collins, L.C.3
Moreland, J.4
-
35
-
-
70349140060
-
Biologics for rheumatoid arthritis: an overview of Cochrane reviews
-
Singh JA, Christensen R, Wells GA, Suarez-Almazor ME, Buchbinder R, Lopez-Olivo MA, et al.Biologics for rheumatoid arthritis: an overview of Cochrane reviews. Cochrane Database of Systematic Reviews 2010, Issue 4. [DOI: 10.1002/14651858.CD007848.pub2]
-
(2010)
Cochrane Database of Systematic Reviews
, Issue.4
-
-
Singh, J.A.1
Christensen, R.2
Wells, G.A.3
Suarez-Almazor, M.E.4
Buchbinder, R.5
Lopez-Olivo, M.A.6
-
36
-
-
77953696525
-
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
-
Smolen JS, Landewé R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, et al.EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Annals of the Rheumatic Diseases 2010;69:964-75.
-
(2010)
Annals of the Rheumatic Diseases
, vol.69
, pp. 964-975
-
-
Smolen, J.S.1
Landewé, R.2
Breedveld, F.C.3
Dougados, M.4
Emery, P.5
Gaujoux-Viala, C.6
-
37
-
-
38449094689
-
Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis
-
Tian H, Cronstein BN. Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis. Bulletin of the NYU Hospital for Joint Diseases 2007;65:168-73.
-
(2007)
Bulletin of the NYU Hospital for Joint Diseases
, vol.65
, pp. 168-173
-
-
Tian, H.1
Cronstein, B.N.2
-
38
-
-
0026501630
-
Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis
-
van der Heijde DM, van't Hof MA, van Riel PL, van Leeuwen MA, van Rijswijk MH, van de Putte LB. Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis. Annals of the Rheumatic Diseases 1992;51:177-81.
-
(1992)
Annals of the Rheumatic Diseases
, vol.51
, pp. 177-181
-
-
van der Heijde, D.M.1
van't Hof, M.A.2
van Riel, P.L.3
van Leeuwen, M.A.4
van Rijswijk, M.H.5
van de Putte, L.B.6
-
39
-
-
0033984107
-
How to read radiographs according to the Sharp/van der Heijde method
-
van der Heijde DM. How to read radiographs according to the Sharp/van der Heijde method. The Journal of Rheumatology 2000;27:261-3.
-
(2000)
The Journal of Rheumatology
, vol.27
, pp. 261-263
-
-
van der Heijde, D.M.1
-
40
-
-
0030068817
-
Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria
-
van Gestel AM, Prevoo ML, van't Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis and Rheumatism 1996;39:34-40.
-
(1996)
Arthritis and Rheumatism
, vol.39
, pp. 34-40
-
-
van Gestel, A.M.1
Prevoo, M.L.2
van't Hof, M.A.3
van Rijswijk, M.H.4
van de Putte, L.B.5
van Riel, P.L.6
-
41
-
-
68049124945
-
Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial
-
van Vollenhoven RF, Ernestam S, Geborek P, Petersson IF, Cöster L, Waltbrand E, et al.Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial. Lancet 2009; Vol. 374:459-66.
-
(2009)
Lancet
, vol.374
, pp. 459-466
-
-
van Vollenhoven, R.F.1
Ernestam, S.2
Geborek, P.3
Petersson, I.F.4
Cöster, L.5
Waltbrand, E.6
-
42
-
-
85041955650
-
WinBUGS
-
1.4.3. Cambridge, UK: Imperial College and Medical Research Council, Aug 6, 2007
-
Imperial College and Medical Research Council. WinBUGS. 1.4.3. Cambridge, UK: Imperial College and Medical Research Council, Aug 6, 2007.
-
-
-
|